Event Brief
Dec 18, 2025 at 12:09 PM ET
Eli Lilly, Novo Nordisk Compete with New Weight-Loss Drugs
By The BriefBrief
Eli Lilly and Novo Nordisk file for FDA approval of new obesity drugs, potentially transforming obesity treatment.
WHO: Eli Lilly, Novo Nordisk
WHAT: Filing for FDA approval of new weight-loss drugs
WHEN: Dec 17, 2025 at 7:00 PM ET
WHERE: United States
WHY: To provide new treatment options for obesity
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Final defendant sentenced in Zaria McKeever murder case
Zaria Mckeever
May 1, 2026 at 3:23 PM ET
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia
May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21416 of 21416
Same format. Every time.
Continue reading — sign in or create a free account with
